Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Jørgen Vestbo, Alberto Papi, Massimo Corradi, Viktor Blazhko, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri, Dave Singh

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

1853 Downloads (Pure)

2 results
- Title(descending)

Clinical trials in chronic obstructive pulmonary disease (COPD) advancing effective combination treatments
Singh, S. (Participant) & Vestbo, J. (Participant)
Impact: Health and wellbeing, Economic
Definitive multinational efficacy trials and pioneering ‘real-world’ evidence informing treatments and international strategy for managing chronic obstructive pulmonary disease (COPD)
Vestbo, J. (Participant), Singh, S. (Participant) & Woodcock, A. (Participant)
Impact: Health and wellbeing